(Q37307804)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Interferon-alpha in the management of patients with Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

David S F Yang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sue L Lightman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Hospital Medicine

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

575-579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18949947%20AND%20SRC:MED&resulttype=core&format=json

The control of T cell activation vs. tolerance

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Interferons as pathogenic effectors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Behçet's disease: ocular effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Current concepts in the etiology and treatment of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Ocular immunopathology of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Biologics in the treatment of uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Interferon therapy for ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

New approaches in the treatment of Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Neovascularization of the optic disc in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317

Clinical Pharmacokinetics of Interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2008.69.10.31317